Replies to post #27829 on SLEEKSCAPE'S 2022 CANNABIS & MARIJUANA MANIA GRAND

[sleekscape]

I requested a paper copy and still haven’t received anything

But even it is December 1st, that would make 1/10/20 the earliest possible date

I’m sure that just like us they want to optimize the timing to do what’s best for the stock — they own a lot of shares, too, and everybody is going through any potential share restructuring together

Getting on the Nasdaq would be an amazing accomplishment

With the legalization of CBD as a dietary supplement, I’m confident the Nasdaq will start accepting Pure CBD Oil companies, so at the bare minimum, CANB would be a very, very solid candidate for uplisting — they have audited annual returns for 2 years and meet all difficult criteria for the Nasdaq Capital tier including $5M shareholder equity and a majority independent board of directors

The other OTC CBD Oil stocks (CV Sciences, Charlotte’s Web, Elixinol, etc) sell Full Spectrum CBD Oil, which I expect to remain federally illegal

Which means CANB would be the only OTC CBD Oil stock that would be eligible for uplisting to the Nasdaq

So that gives them a pretty good shot at becoming the first American CBD Oil stock to uplist


Sleek